Prostaglandin-inhibitor analgesics
Medical Letter on Drugs and Therapeutics 23(17): 75-76
1981
ISSN/ISBN: 0025-732X PMID: 7266423 Document Number: 173342
Document emailed within 1 workday
Related Documents
Shimkovich, M.V.; Pshennikova, M.G. 1986: Effect of preliminary administration of prostaglandin E2 and the prostaglandin synthesis inhibitor indomethacin on disturbances of myocardial contraction during stress Biulleten' Eksperimental'noi Biologii i Meditsiny 101(5): 536-537Ukhal', M.I.; Melenevskiĭ, D.A. 2004: Using prostaglandin inhibitor dicloberl in patients with ureteral calculi Likars'ka Sprava 2: 76-78
Sharif, N.A.; Xu, S.X.; Williams, G.W.; Crider, J.Y.; Griffin, B.W.; Davis, T.L. 1998: Pharmacology of [3H]prostaglandin E1/[3H]prostaglandin E2 and [3H]prostaglandin F2alpha binding to EP3 and FP prostaglandin receptor binding sites in bovine corpus luteum: characterization and correlation with functional data Journal of Pharmacology and Experimental Therapeutics 286(2): 1094-1102
Watanabe, K.; Iguchi, Y.; Iguchi, S.; Arai, Y.; Hayaishi, O.; Roberts, L.J. 1986: Stereospecific conversion of prostaglandin D2 to (5Z,13E)-(15S)-9 alpha-11 beta,15-trihydroxyprosta-5,13-dien-1-oic acid (9 alpha,11 beta-prostaglandin F2) and of prostaglandin H2 to prostaglandin F2 alpha by bovine lung prostaglandin F synthase Proceedings of the National Academy of Sciences of the United States of America 83(6): 1583-1587
Malec, D.; Grabowska, E.; Langwiński, R. 1978: Central action of narcotic analgesics. Part IV. Noradrenergic influences on the activity of analgesics in rats Polish Journal of Pharmacology and Pharmacy 30(5): 627-637
Andreini, F.; Biagi, G.; Giorgi, I.; Livi, O.; Scartoni, V. 1989: Modification of the 1,2,3-triazole ring present in an effective in vitro inhibitor of the prostaglandin synthesis Farmaco 44(9): 831-841
Adams, T.; Traber, D.L. 1982: The effects of a prostaglandin synthetase inhibitor, ibuprofen, on the cardiopulmonary response to endotoxin in sheep Circulatory Shock 9(5): 481-489
Batislam, E.; Nuhoğlu, B.; Peşkircioğlu, L.; Emir, L.; Uygur, C.; Germiyanoğlu, C.; Erol, D. 1995: A prostaglandin synthesis inhibitor, diclofenac sodium in the treatment of primary nocturnal enuresis Acta Urologica Belgica 63(3): 35-38
Dequeker, J.; Geusens, P.; Verstraeten, A.; Vanderschueren, D.; Nijs, J. 1991: 1,25-Dihydroxyvitamin D3 stimulation test and the effect of a prostaglandin synthesis inhibitor (piroxicam) in young adults Mineral and Electrolyte Metabolism 17(6): 353-356
Kaijser, L.; Eklund, B.; Olsson, A.G.; Carlson, L.A. 1979: Dissociation of the effects of nicotinic acid on vasodilatation and lipolysis by a prostaglandin synthesis inhibitor, indomethacin, in man Medical Biology 57(2): 114-117
Murayama, K.; Kasai, H.; Adachi, T.; Utsunomiya, O.; Ouchi, H. 1983: Comparative study of prostaglandin I2 (PG I2) and thromboxane A2 (TXA2) synthetase inhibitor (OKY-1581) on hemodynamics in pregnant dogs Nihon Sanka Fujinka Gakkai Zasshi 35(3): 344-350
Smith, R.J.; Sun, F.F.; Bowman, B.J.; Iden, S.S.; Smith, H.W.; Mcguire, J.C. 1982: Effect of 6,9-deepoxy-6,9-(phenylimino)-delta 6,8-prostaglandin 1(1) (U-60,257), an inhibitor of leukotriene synthesis, on human neutrophil function Biochemical and Biophysical Research Communications 109(3): 943-949
Paradowski, A.; Miazgowski, T.; Ogonowski, J.; Cretti, A. 1983: The effect of prostaglandin synthetase inhibitor on pressor reaction during intravenous infusion of angiotensin II in pregnant rabbits Ginekologia Polska 54(7): 445-451
Schölkens, B.A. 1974: Experimental, acute renal hypertension and exogenous angiotensin Ii administration following premedication with the prostaglandin biosynthesis inhibitor indometacin Verhandlungen der Deutschen Gesellschaft für Innere Medizin 80: 285-288
De Clerck, F.; Vermylen, J.; Reneman, R. 1975: Effects of suprofen, an inhibitor of prostaglandin biosynthesis, on platelet function, plasma coagulation and fibrinolysis. I. in vitro experiments Archives Internationales de Pharmacodynamie et de Therapie 216(2): 263-279
Malec, D.; Langwiński, R. 1981: Central action of narcotic analgesics. VIII. the effect of dopaminergic stimulants on the action of analgesics in rats Polish Journal of Pharmacology and Pharmacy 33(3): 273-282
Malec, D.; Fidecka, S.; Langwiński, R. 1977: Central action of narcotic analgesics. I. Catalepsy and stereotypy in rats and narcotic analgesics Polish Journal of Pharmacology and Pharmacy 29(3): 177-193
Chiabrando, C.; Broggini, M.; Castelli, M.G.; Cozzi, E.; Castagnoli, M.N.; Donelli, M.G.; Garattini, S.; Giavazzi, R.; Fanelli, R. 1987: Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor Cancer Research 47(4): 988-991
Riedo, F.X.; Munford, R.S.; Campbell, W.B.; Reisch, J.S.; Chien, K.R.; Gerard, R.D. 1990: Deacylated lipopolysaccharide inhibits plasminogen activator inhibitor-1, prostacyclin, and prostaglandin E2 induction by lipopolysaccharide but not by tumor necrosis factor-alpha Journal of Immunology 144(9): 3506-3512
Laurell, M.; Stenflo, J. 1989: Protein C inhibitor from human plasma: characterization of native and cleaved inhibitor and demonstration of inhibitor complexes with plasma kallikrein Thrombosis and Haemostasis 62(3): 885-891